AKA: ['Gamma Hydroxybutyric Acid', 'gamma hydroxybutyrate', 'sodium oxybate']
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
III. Chemical Profile ( IUPAC name)
|
IV. History
Gamma Hydroxybutyric Acid (GHB) was originally synthesized in the 1960s as a potential anesthetic. It gained popularity in the 1980s and 1990s as a recreational drug due to its sedative and euphoric effects. It was later classified as a Schedule I controlled substance due to its abuse potential and lack of recognized medical use.
|
V. Legal Information
Gamma Hydroxybutyric Acid (GHB) is illegal in most countries, including the United States, where it is classified as a Schedule I controlled substance. Possession, distribution, and manufacture are strictly regulated and penalized.
Unknown Schedule
No description available.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
GHB acts as a central nervous system depressant by affecting GABA receptors. It induces sedation, muscle relaxation, and can lead to unconsciousness at higher doses. Physiological effects include slowed heart rate and breathing.
|
VII. Psychological Effects
Psychologically, GHB can cause euphoria, reduced inhibitions, and feelings of relaxation. However, it can also lead to confusion, dizziness, and memory loss, particularly in higher doses.
|
|
|
